Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands

Archives of Internal Medicine

Volumn 168, Issue 17, 2008, Pages 1890-1896

  Leendertse, Anne J ^a,b   Egberts, Antoine C G ^a,b   Stoker, Lennart J ^c,e   Van Den Bemt, Patricia M L A ^a,d  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c Diakonessen Huis   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e Altrecht Institute for Mental Healthcare   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIINFECTIVE AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CORTICOSTEROID DERIVATIVE; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LAXATIVE; LOPERAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; ORAL ANTIDIABETIC AGENT;

ARTICLE; CARDIOVASCULAR SYMPTOM; CASE CONTROL STUDY; COGNITIVE DEFECT; COMORBIDITY; CONTROLLED STUDY; DRUG INDUCED DISEASE; ELECTIVE SURGERY; ENDOCRINE DISEASE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; NETHERLANDS; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; POLYPHARMACY; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RISK FACTOR;

AGE FACTORS; AGED; CASE-CONTROL STUDIES; COGNITION DISORDERS; COMORBIDITY; FEMALE; HOSPITALIZATION; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; NETHERLANDS; PATIENT COMPLIANCE; PHARMACEUTICAL PREPARATIONS; POLYPHARMACY; PROSPECTIVE STUDIES; RISK FACTORS; SURGICAL PROCEDURES, ELECTIVE; TREATMENT OUTCOME;

EID: 52649138472     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2008.3     Document Type: Article

References (31)

1. Kohn L, Corrigan J, Donaldson M; Committee on Quality of Health Care in America, Institute of Medicine. To Err Is Human: Building a Safer Health System. Washington, DC: National Academy Press; 1999.
2. Beijer HJ, de Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci. 2002;24(2):46-54.
3. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279 (15):1200-1205.
4. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329(7456):15-19.
5. Queneau P, Bannwarth B, Carpentier F, et al; Association Pédagogique Nationale pour l'Enseignement de la Thérapeutique (APNET). Emergency department visits caused by adverse drug events. Drug Saf. 2007;30(1):81-88.
6. Howard RL, Avery AJ, Howard PD, Patridge M. Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study. Qual Saf Health Care. 2003;12(4):280-285.
7. Pouyanne P, Haramburu F, Imbs JL, Bégaud B; for the French Pharmacovigilance Centres. Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. BMJ. 2000;320(7241):1036..
8. von Euler M, Eliasson E, Öhlén G, Bergman U. Adverse drug reactions causing hospitalization can be monitored from computerized medical records and thereby indicate the quality of drug utilization. Pharmacoepidemiol Drug Saf. 2006;15(3):179-184.
9. Stewart RB, Sprinker PK, Adams JE. Drug-related admissions to an inpatient psychiatric unit. Am J Psychiatry. 1980;137(9):1093-1095.
10. van der Hooft CS, Sturkenboom MCJM, Van Grootheest K, Kingma HJ, Stricker BHC. Adverse drug reaction-related hospitalizations: a nationwide study in the Netherlands. Drug Saf. 2006;29(2):161-168.
11. Waller P, Shaw M, Ho D, Shakir S, Ebrahim S. Hospital admissions for "druginduced" disorders in England: a study using the Hospital Episodes Statistics (HES) database. Br J Clin Pharmacol. 2005;59(2):213-219.
12. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356(9237):1255-1259.
13. van den Bemt PM, Egberts ACG, de Jong-van den Berg LT, Brouwers JR. Drugrelated problems in hospitalised patients. Drug Saf. 2000;22(4):321-333.
14. Ministerie van Volksgezondheid, Welzijn en Sport. Brancherapport ziekenhuiszorg. http://www.brancherapporten.minvws.nl/object_document/o323n399. html. Accessed June 25, 2007.
15. Aronson JK. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. 14th ed. Amsterdam, the Netherlands: Elsevier; 2000.
16. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31-41.
17. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50(1):105-116.
18. Kramer MS, Leventhal JM, Hutchinson TA, Feinstein AR. An algorithm for the operational assessment of adverse drug reactions, I: background, description, and instructions for use. JAMA. 1979;242(7):623-631.
19. Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm. 1992;27(6):538.
20. Kuijpers MA, van Marum RJ, Egberts AC, Jansen PA. Relationship between polypharmacy and underprescribing. Br J Clin Pharmacol. 2008;65(1):130-133.
21. Rollason V, Vogt N. Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist. Drugs Aging. 2003;20(11):817-832.
22. Hampel FR, Ronchetti EM, Rousseeuw PJ, Stahel WA. Robust Statistics: The Approach Based on Influence Functions. New York, NY: John Wiley & Sons; 1986.
23. Howard RL, Avery AJ, Slavenburg S, et al. Which drugs cause preventable admissions to hospital? a systematic review. Br J Clin Pharmacol. 2007;63(2):136-147.
24. Hanlon JT, Pieper CF, Hajjar ER, et al. Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay. J Gerontol A Biol Sci Med Sci. 2006;61(5):511-515.
25. Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med. 1990;150(4):841-845.
26. Zargarzadeh AH, Emami MH, Hosseini F. Drug-related hospital admissions in a generic pharmaceutical system. Clin Exp Pharmacol Physiol. 2007;34(5-6):494-498.
27. Patel KJ, Kedia MS, Bajpai D, Mehta SS, Kshirsagar NA, Gogtay NJ. Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective study. BMC Clin Pharmacol. 2007;7:8. doi:10.1186/1472-6904-7- 8.
28. Rivkin A. Admissions to a medical intensive care unit related to adverse drug reactions. Am J Health Syst Pharm. 2007;64(17):1840-1843.
29. Onder G, Pedone C, Landi F, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc. 2002;50(12):1962-1968.
30. Williamson J, Chopin J. Adverse reactions to prescribed drugs in the elderly: a multicentre investigation. Age Ageing. 1980;9(2):73-80.
31. Schneeweiss S, Hasford J, Göttler M, Hoffmann A, Riethling AK, Avorn J. Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin Pharmacol. 2002;58(4):285-291.